A double blind, randomized, placebo-controlled, single center, parallel group study to evaluate the effects of itopride (100 mg and 200 mg t.i.d.) on gastric motor and sensory functions in healthy volunteers

Trial Profile

A double blind, randomized, placebo-controlled, single center, parallel group study to evaluate the effects of itopride (100 mg and 200 mg t.i.d.) on gastric motor and sensory functions in healthy volunteers

Completed
Phase of Trial: Phase II/III

Latest Information Update: 26 Jan 2010

At a glance

  • Drugs Itopride (Primary)
  • Indications Gastritis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top